India Temporarily Halts AstraZeneca Vaccine Exports..."Domestic Supply Priority"

Export Suspension Until April Due to Rapid COVID-19 Surge in India
60 Million Doses Exported to 76 Countries from India...Supply Impact Expected

[Image source=Reuters Yonhap News]

[Asia Economy Reporter Lee Hyun-woo] The Indian government announced that it will temporarily halt exports of the AstraZeneca COVID-19 vaccine produced domestically until April due to the worsening COVID-19 situation. There are concerns that a prolonged export suspension by India, which accounts for 60% of the world's vaccine production, could lead to a global vaccine supply shortage.

According to the BBC on the 24th (local time), the Indian government stated that it will temporarily suspend exports of vaccines produced domestically, including the AstraZeneca and Novavax vaccines. The government plans to halt vaccine exports until the end of April to secure 100 million doses for domestic use. The BBC reported that shipments of 5 million doses of the AstraZeneca vaccine, scheduled to be shipped from India to the UK, Brazil, and Saudi Arabia since last week, have been delayed.

The reason for India's decision to temporarily suspend vaccine exports is due to the resurgence of COVID-19 spread within the country. The Indian government announced that starting from May 1, the vaccination target will be expanded nationwide to all individuals aged 45 and older to curb the spread of COVID-19. Consequently, vaccine demand is expected to surge, leading to the temporary export suspension. An Indian Foreign Ministry official told the BBC in an interview, "Domestic demand takes priority right now," adding, "However, the export suspension is a temporary measure, and supply may resume from May."

India began vaccinations on January 16, but so far, about 47 million people have been vaccinated. Considering the population of over 1.3 billion, the vaccination rate remains very low. Indian authorities plan to vaccinate more than 600 million citizens within the next seven months, requiring approximately 85 million doses per month.

India is the largest vaccine producer, supplying over 60% of the world's vaccines, and has exported more than 60 million doses of COVID-19 vaccines to 76 countries to date. Especially, the vaccines supplied to low-income countries through the 'COVAX facility' project largely depend on Indian production, raising serious concerns about worsening vaccine shortages in these countries.

This content was produced with the assistance of AI translation services.